LWM
PJP icon

Lodestone Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Lodestone Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.3K Buy
+205
New +$25.5K 0.01% 402

Other funds holding PJP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
MWM
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

Lodestone Wealth Management's PJP Position: Q3 2026 in Review

Lodestone Wealth Management opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 205 shares worth $25.3K. The stake represents 0.01% of the portfolio and ranks #402 among its holdings.

13 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Lodestone Wealth Management held 205 shares of Invesco Pharmaceuticals ETF worth $25.3K as of Q3 2026.
  • Invesco Pharmaceuticals ETF was a new Lodestone Wealth Management position in Q3 2026.
  • Invesco Pharmaceuticals ETF made up 0.01% of Lodestone Wealth Management's portfolio in Q3 2026, its #402 holding.
  • 13 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Lodestone Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.